Table 4 Cox regression analysis for prediction of the primary endpoint using a single variable in ECLS recipients

Age, years

1.026

0.029

1.003

1.050

Sex, male

1.004

0.992

0.428

2.359

Slope 5

0.031

0.003

0.003

0.306

Area 6 to 20

0.992

0.004

0.987

0.997

Area 6 to 40

0.982

0.004

0.971

0.994

Inotropic equivalent, μg/kg per minute

0.998

0.374

0.993

1.003

APACHE score

1.069

0.005

1.020

1.121

SOFA score

1.105

0.054

0.998

1.224

LODS

1.160

0.001

1.060

1.270

MODS

1.176

0.003

1.058

1.307

Diabetes mellitus

1.112

0.799

0.492

2.515

Stroke

3.121

0.124

0.733

13.298

Chronic obstructive pulmonary disease

0.670

0.695

0.090

4.963

End-stage renal disease

0.441

0.423

0.060

3.256

Coronary artery disease history

0.981

0.966

0.399

2.411

Prior myocardial infarction

3.922

0.032

1.125

13.667

Heart failure

1.623

0.219

0.750

3.510

Hypertension

0.981

0.962

0.445

2.161

Current smoking

1.704

0.168

0.799

3.634

ECLS indication, cardiogenic versus non-cardiogenic

1.508

0.301

0.692

3.285